[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 5, 1982

Implantable Insulin Infusion Devices

Author Affiliations

Massachusetts General Hospital Boston

JAMA. 1982;248(17):2111. doi:10.1001/jama.1982.03330170019006

To the Editor.—  In the editorial by Service et al (1982;247:1866), they urge extreme caution in the clinical use of both extracorporeal and implantable insulin infusion devices. Since the use of external infusion devices has been associated with substantial morbidity and mortality and intensive conventional therapy has been shown to provide similar glycemic control in both short- and long-term studies, we believe that both types of devices should be used only in carefully supervised research protocols at present.However, we must disagree with part of the following contention of Service et al:... that implantation of insulin delivery systems into humans is not justified other than for acute and closely supervised experiments designed to answer questions that cannot be answered adequately in animal studies (italics ours).Some of us have much experience with implantable drug delivery systems, and we believe that the implantation of devices of this type is not justified